Compound

D1030 | olvanil

Molecular Formula C26H43NO3
Molecular Weight 417.6
Structure

Toxicity Dose Time Species Model Method Action Positive criterion Reference
MEMBRANE POTENTIAL 13.53±1.90 human qHTS-HepG2 MMP assay decrease IC50 163
MEMBRANE POTENTIAL human HepG2 MMP assay Negative IC50 163
MEMBRANE POTENTIAL rat hepatocytes MMP assay Negative IC50 163


  • (9Z)-N-(4-Hydroxy-3-methoxybenzyl)-9-octadecenamide # (9Z)-N-[(4-hydroxy-3-methoxyphenyl)methyl]octadec-9-enamide (N-Vanillyl)-9-oleamide
    (Z)-N-[(4-hydroxy-3-methoxy-phenyl)methyl]octadec-9-enamide (Z)-N-[(4-hydroxy-3-methoxyphenyl)methyl]octadec-9-enamide (Z)-Octadec-9-enoic acid, amide, N-(4-hydroxy-3-methoxyphenyl)-;
    1967AH 3-13-00-02192 (Beilstein Handbook Reference) 4P7KIU7003
    58493-49-5 9-Octadecenamide, N-((4-hydroxy-3-methoxyphenyl)methyl)-, (Z)- 9-Octadecenamide, N-[(4-hydroxy-3-methoxyphenyl)methyl]-, (Z)-
    AKOS024458705 B6512 BDBM20460
    BN0398 CAS-58493-49-5 CCG-221972
    CHEMBL76903 D05249 DSSTox_CID_25669
    DSSTox_GSID_45669 DSSTox_RID_81044 DTXSID1045669
    GTPL2488 HMS3262E17 HMS3411J12
    HMS3649J03 HMS3675J12 LP00668
    MFCD00673962 N-((4-Hydroxy-3-methoxyphenyl)methyl)-9-octadecenamide (Z)- N-Vanillyloleamide
    N-Vanillyloleoylamide N-Vannilyloleoylamide NCGC00024885-01
    NCGC00024885-02 NCGC00024885-03 NCGC00261353-01
    NE 19550 NE-19550 OLVANIL
    OPZKBPQVWDSATI-KHPPLWFESA-N Olvanil (USAN) Olvanil [USAN:INN]
    Olvanil, powder Olvanilo Olvanilo [Spanish]
    Olvanilum Olvanilum [Latin] Q27088176
    SCHEMBL94262 SR-01000597478 SR-01000597478-1
    SR-01000597478-3 TCMDC-124289 Tocris-0934
    Tox21_110935 Tox21_110935_1 Tox21_500668
    UNII-4P7KIU7003 Vanillyloleamide ZINC8036019

    CAS Number 58493-49-5
    PubChem Compound 5311093
    KEGG Drug D05249